Journal
JOURNAL OF PARKINSONS DISEASE
Volume 1, Issue 1, Pages 83-92Publisher
IOS PRESS
DOI: 10.3233/JPD-2011-11004
Keywords
Neural; transplantation; graft survival; dopamine; phenotype; tyrosine hydroxylase; alpha-synuclein; Lewy bodies
Categories
Funding
- Swedish Research Council
- Swedish Parkinson Foundation
- Nordic Center of Excellence on Neurodegeneration
- Strong Research Environment of the Swedish Research Council (NeuroFortis)
- Linne grant (BAGADILICO)
Ask authors/readers for more resources
We demonstrate that grafted human fetal mesencephalic neurons can survive and extend axons for 22 years in the brain of a patient with Parkinson's disease (PD). In this patient, the overall survival and fiber outgrowth of the grafts were, however, relatively poor, which is consistent with the lack of significant clinical graft-induced benefit. We have compared the morphology of neurons in the 22-year old grafts with those in two younger grafts (16- and 12-year old), which were sequentially implanted in another PD patient. In the case with the 22-year-old transplant, a high proportion (up to 38%) of the grafted dopaminergic (pigment-granule containing) neurons do not express tyrosine hydroxylase and dopamine transporter and their perikarya appear atrophic. The proportion of pigmented neurons not expressing these markers is lower in the 12-16 year old grafts. Furthermore, in the 22-year-old graft, 49% of the pigmented neurons display alpha-synuclein immunoreactivity in the cell body and 1.2% of them contain Lewy bodies. In conclusion, our results show that grafted dopaminergic neurons can survive for more than two decades. However, over time an increasing proportion of grafted neurons exhibit signs of degeneration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available